Trader Note — 9345 total
ENRD, the Swedish autonomous freight startup Einride AB, posted a jarring single-session decline this week, dropping 10.8% to $9.39 on June 12 — and the borrow market tells an equally unsettled story. The most striking…
VAR dropped 5.4% on Friday alone, closing at NOK 47.02 — a steeper single-day move than any of its closest Oslo Børs peers. The selloff arrives against a curious lending-market backdrop: borrow demand spiked sharply…
NXDR heads into the back half of June with a peculiar split: a cost-to-borrow that tripled in two days and a borrow market that remains among the loosest in the market. The cost-to-borrow story is the week's standout.…
IonQ arrives at its June 16 earnings report with the most dramatic short unwind of the past month still fresh — and a Street that cannot agree on what the stock is worth. The positioning story has shifted more in the…
SPCE is now dealing with the hangover from one of the sharpest two-act trades of the year — a 40%-plus one-month rally built on SpaceX anticipation, followed by a 32% single-day collapse the moment the real deal began…
SATS has added another 2.3% this week, and the picture emerging from the data is one of a stock where the bears have largely moved on and the institutional buyer base continues to quietly grow. The borrow market…
MOS heads into the weekend with a sharp one-day reversal sitting on top of a still-growing short position — a tension that defines where this stock is right now. Short interest at Mosaic has risen fast and far. SI as a…
Zhejiang Shuanghuan Driveline is holding at CNY 41.00 after a rough week, down 4.3%, while the broader Chinese auto parts complex trades even weaker — the tension now is whether the Street's 20% upside target reflects…
CDR enters the week with a striking internal contradiction: its fundamental growth story has rarely looked stronger, yet the stock has shed 14% over the past month and short sellers have quietly been rebuilding…
CAR Group enters the week with shorts continuing to accumulate — yet the gap between that growing conviction and the relaxed lending market remains the defining tension in this name. The short position keeps expanding…
Capricor Therapeutics heads into the weekend with a stock that bounced 3% on Friday but remains 18% below where it traded a month ago — and a short position that has stabilised rather than retreated. The bear…
KR enters Thursday's Q1 earnings print with short interest freshly rebuilt, analyst targets drifting lower, and a stock that has barely moved in a month — a setup that is cautious without being alarming. The short…
RMIX has been the week's most charged name in construction materials — stock up 27% in five days, short interest nearly doubling, and four analyst initiations still fresh on the tape. The price move is the headline.…
GLXY enters the back half of June having just printed one of its sharpest weekly moves in recent memory — a 33% gain in five sessions to $33.36 — while short sellers and insiders are both quietly pressing in the…
Climb Bio enters the week with the most notable analyst activity it has seen since its rebranding, as a fresh initiation from Guggenheim sets a price target that stands well above the rest of the Street. The analyst…
Amerant Bancorp has spent the week drifting higher alongside a broadly constructive regional bank tape, but the stock's 5% weekly gain stands out for how little short-side pressure is driving it. The lending market…
NTR heads into its August earnings window with a notable insider buying cluster at its back and short sellers quietly stepping away from the name. The most compelling angle this week is what happened inside the company…
SPCX commands an enterprise value north of $821 billion, yet the ownership structure leaves almost nothing for the market to actually trade. The concentration here is genuinely unusual. Elon Musk holds 46.4% of shares…
RYTM enters its June 24 earnings report with a notable split: short sellers have been quietly trimming positions, while options traders have swung to their most bullish stance in months. The options picture is the…
Ocular Therapeutix heads into a pivotal stretch with options traders at their most bullish in months — and a formal readout event just days away. The sharpest signal this week is in options. The put/call ratio has…
